Clinical Trial

Post-Trial Access to ATH434 for Patients With Multiple System Atrophy

Name: Post-Trial Access to ATH434 for Patients With Multiple System Atrophy — clinical trial record (NCT07531433)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Available

View on ClinicalTrials.gov →

Summary

This multicenter post-trial access program is designed to provide ATH434 orally BID to eligible patients who completed Phase 2 studies ATH434-201 or ATH434-202, and who may benefit from this treatment according to the evaluation by their treating physicians.

Trial Details

NCT Number	NCT07531433
Lead Sponsor	Alterity Therapeutics
Conditions	Multiple System Atrophy
Updated on ClinicalTrials.gov	2026-04-15